Healthcare resource utilization in patients with metastatic melanoma receiving first-line therapy with dabrafenib + trametinib versus nivolumab or pembrolizumab monotherapy
Ghate, Sameer R., Ionescu-Ittu, Raluca, Burne, Rebecca, Ndife, Briana, Laliberté, François, Nakasato, Antonio, Duh, Mei ShengLanguage:
english
Journal:
Current Medical Research and Opinion
DOI:
10.1080/03007995.2018.1501351
Date:
July, 2018
File:
PDF, 1.19 MB
english, 2018